RhumbLine Advisers
MNOV icon

RhumbLine Advisers’s MediciNova MNOV Stock Holding History

RhumbLine Advisers’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-49,059
Closed -$248K – 3066
2021
Q1 		$248K Sell
49,059
-2,040
-4% -$11.9K ﹤0.01% 2766
2020
Q4 		$269K Buy
51,099
+3,150
+7% +$18.1K ﹤0.01% 2714
2020
Q3 		$251K Sell
47,949
-7,255
-13% -$41.8K ﹤0.01% 2596
2020
Q2 		$299K Buy
55,204
+2,210
+4% +$11.7K ﹤0.01% 2579
2020
Q1 		$197K Hold
52,994
– – ﹤0.01% 2590
2019
Q4 		$357K Buy
52,994
+280
+0.5% +$2.11K ﹤0.01% 2512
2019
Q3 		$419K Sell
52,714
-400
-0.8% -$3.57K ﹤0.01% 2410
2019
Q2 		$511K Buy
53,114
+1,586
+3% +$16.7K ﹤0.01% 2351
2019
Q1 		$427K Sell
51,528
-1,350
-3% -$11.8K ﹤0.01% 2393
2018
Q4 		$432K Buy
52,878
+17,285
+49% +$172K ﹤0.01% 2363
2018
Q3 		$445K Sell
35,593
-2,350
-6% -$23.6K ﹤0.01% 2323
2018
Q2 		$302K Buy
37,943
+5,153
+16% +$53.3K ﹤0.01% 2529
2018
Q1 		$335K Buy
32,790
+2,770
+9% +$27.6K ﹤0.01% 2384
2017
Q4 		$194K Sell
30,020
-7,033
-19% -$46.6K ﹤0.01% 2642
2017
Q3 		$236K Buy
37,053
+780
+2% +$4.15K ﹤0.01% 2656
2017
Q2 		$191K Buy
36,273
+3,865
+12% +$21.7K ﹤0.01% 2775
2017
Q1 		$194K Buy
32,408
+1,392
+4% +$8.39K ﹤0.01% 2659
2016
Q4 		$187K Buy
31,016
+2,329
+8% +$16.4K ﹤0.01% 2691
2016
Q3 		$215K Buy
28,687
+3,800
+15% +$25.6K ﹤0.01% 2640
2016
Q2 		$188K Buy
+24,887
New +$180K ﹤0.01% 2772

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RhumbLine Advisers's MNOV Position: Q2 2021 in Review

RhumbLine Advisers sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 49,059 shares — an estimated $248K sold.

RhumbLine Advisers first reported a position in MNOV in Q2 2016 and held it in 20 quarters. The position peaked at $511K in Q2 2019. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

  • RhumbLine Advisers reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
  • RhumbLine Advisers sold 49,059 MediciNova shares in Q2 2021, an estimated $248K.
  • RhumbLine Advisers first reported a position in MediciNova in Q2 2016 and held it in 20 quarters.
  • RhumbLine Advisers's MediciNova position peaked at $511K in Q2 2019.
  • 55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.